29592817|t|Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.
29592817|a|Amyotrophic lateral sclerosis (ALS) is rapidly progressive adult-onset motor neuron disease characterized by the neurodegeneration of both upper and lower motor neurons in the cortex and the spinal cord; the majority of patients succumb to respiratory failure. Although the etiology is not yet fully understood, there is compelling evidence that ALS is a multi-systemic disorder, with peripheral inflammation critically contributing to the disease process. However, the full extent and nature of this immunological dysregulation remains to be established, particularly within circulating blood cells. Therefore, the aim of the present study was to identify dysregulated inflammatory molecules in peripheral blood cells of ALS patients and analyze for functional consequences of the observed findings. To this end, we employed flow cytometry-based screening to quantify the surface expression of major chemokine receptors and integrins. A significantly increased expression of CXCR3, CXCR4, CCL2, and CCL5 was observed on T cells in ALS patients compared to healthy controls. Intriguingly, the expression was even more pronounced in patients with a slow progressive phenotype. To further investigate the functional consequences of this altered surface expression, we used a modified Boyden chamber assay to measure chemotaxis in ALS patient-derived lymphocytes. Interestingly, chemoattraction with the CXCR3-Ligand IP10 led to upregulated migratory behavior of ALS lymphocytes compared to healthy controls. Taken together, our data provides evidence for a functional dysregulation of IP10-directed chemotaxis in peripheral blood cells in ALS patients. However, whether the chemokine itself or its receptor CXCR3, or both, could serve as potential therapeutic targets in ALS requires further investigations.
29592817	79	82	ALS	Disease	MESH:D000690
29592817	83	91	patients	Species	9606
29592817	93	122	Amyotrophic lateral sclerosis	Disease	MESH:D000690
29592817	124	127	ALS	Disease	MESH:D000690
29592817	164	184	motor neuron disease	Disease	MESH:D016472
29592817	206	223	neurodegeneration	Disease	MESH:D019636
29592817	313	321	patients	Species	9606
29592817	333	352	respiratory failure	Disease	MESH:D012131
29592817	439	442	ALS	Disease	MESH:D000690
29592817	489	501	inflammation	Disease	MESH:D007249
29592817	594	621	immunological dysregulation	Disease	MESH:D007154
29592817	763	775	inflammatory	Disease	MESH:D007249
29592817	815	818	ALS	Disease	MESH:D000690
29592817	819	827	patients	Species	9606
29592817	1069	1074	CXCR3	Gene	2833
29592817	1076	1081	CXCR4	Gene	7852
29592817	1083	1087	CCL2	Gene	6347
29592817	1093	1097	CCL5	Gene	6352
29592817	1125	1128	ALS	Disease	MESH:D000690
29592817	1129	1137	patients	Species	9606
29592817	1225	1233	patients	Species	9606
29592817	1421	1424	ALS	Disease	MESH:D000690
29592817	1425	1432	patient	Species	9606
29592817	1494	1499	CXCR3	Gene	2833
29592817	1507	1511	IP10	Gene	3627
29592817	1553	1556	ALS	Disease	MESH:D000690
29592817	1676	1680	IP10	Gene	3627
29592817	1730	1733	ALS	Disease	MESH:D000690
29592817	1734	1742	patients	Species	9606
29592817	1798	1803	CXCR3	Gene	2833
29592817	1862	1865	ALS	Disease	MESH:D000690
29592817	Association	MESH:D000690	2833
29592817	Association	MESH:D000690	3627
29592817	Positive_Correlation	MESH:D000690	6352
29592817	Positive_Correlation	MESH:D000690	6347
29592817	Positive_Correlation	MESH:D000690	7852
29592817	Bind	2833	3627

